November 5, 2026
Fueling the Future: HudsonAlpha Unveils ‘The Primer Lab’ to Supercharge Alabama’s Biotech Ecosystem fueling-the-future-hudsonalpha-unveils-the-primer-lab-to-supercharge-alabamas-biotech-ecosystem-4

Fueling the Future: HudsonAlpha Unveils ‘The Primer Lab’ to Supercharge Alabama’s Biotech Ecosystem

Reynand Wu October 16, 2026
HUNTSVILLE, AL – In a strategic move to solidify Alabama’s position as a powerhouse in the life...
Read More Read more about Fueling the Future: HudsonAlpha Unveils ‘The Primer Lab’ to Supercharge Alabama’s Biotech Ecosystem
Groundbreaking Research from OU Uncovers How Aggressive Breast Cancer Manipulates Immune System to Fuel Growth, Paving Way for Novel Therapies groundbreaking-research-from-ou-uncovers-how-aggressive-breast-cancer-manipulates-immune-system-to-fuel-growth-paving-way-for-novel-therapies

Groundbreaking Research from OU Uncovers How Aggressive Breast Cancer Manipulates Immune System to Fuel Growth, Paving Way for Novel Therapies

Azzam Bilal Chamdy October 16, 2026
Norman, OK – In a significant stride against one of the most formidable adversaries in oncology, researchers...
Read More Read more about Groundbreaking Research from OU Uncovers How Aggressive Breast Cancer Manipulates Immune System to Fuel Growth, Paving Way for Novel Therapies
Verastem Oncology Set to Advance KRAS Inhibitor VS-7375 to Phase III Trials Following Promising Data in Pancreatic, Colorectal, and Lung Cancers verastem-oncology-set-to-advance-kras-inhibitor-vs-7375-to-phase-iii-trials-following-promising-data-in-pancreatic-colorectal-and-lung-cancers

Verastem Oncology Set to Advance KRAS Inhibitor VS-7375 to Phase III Trials Following Promising Data in Pancreatic, Colorectal, and Lung Cancers

Nana Muazin October 16, 2026
[City, State] – [Date] – Verastem Oncology is poised to accelerate the development of its novel KRAS...
Read More Read more about Verastem Oncology Set to Advance KRAS Inhibitor VS-7375 to Phase III Trials Following Promising Data in Pancreatic, Colorectal, and Lung Cancers
Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Latest Research Suggests navigating-the-intersection-of-glp-1-medications-and-breast-cancer-what-the-latest-research-suggests

Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Latest Research Suggests

Iffa Jayyana October 16, 2026
By Douglas Feil, NBCF Chief Program Officer In recent years, glucagon-like peptide-1 (GLP-1) medications have emerged as...
Read More Read more about Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Latest Research Suggests
A Global Beacon of Hope: 325 Landmarks to Illuminate for National Metastatic Breast Cancer Awareness Day a-global-beacon-of-hope-325-landmarks-to-illuminate-for-national-metastatic-breast-cancer-awareness-day-1

A Global Beacon of Hope: 325 Landmarks to Illuminate for National Metastatic Breast Cancer Awareness Day

Layla Zulfa October 16, 2026
NEW YORK, NY — As the world enters the second week of October, a month traditionally synonymous...
Read More Read more about A Global Beacon of Hope: 325 Landmarks to Illuminate for National Metastatic Breast Cancer Awareness Day
The Dawn of De-escalation: CompassHER2-pCR Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Treatment the-dawn-of-de-escalation-compassher2-pcr-trial-signals-a-paradigm-shift-in-her2-positive-breast-cancer-treatment

The Dawn of De-escalation: CompassHER2-pCR Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Treatment

Sagoh October 16, 2026
For decades, the standard of care for aggressive breast cancer followed a "more is better" philosophy. In...
Read More Read more about The Dawn of De-escalation: CompassHER2-pCR Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Treatment
Global Health Leadership in Focus: WHO Director-General Dr. Tedros Concludes Landmark State Visit to Jordan global-health-leadership-in-focus-who-director-general-dr-tedros-concludes-landmark-state-visit-to-jordan

Global Health Leadership in Focus: WHO Director-General Dr. Tedros Concludes Landmark State Visit to Jordan

Pevita Pearce October 16, 2026
AMMAN, Jordan – The World Health Organization (WHO) Director-General, Dr. Tedros Adhanom Ghebreyesus, has concluded a pivotal...
Read More Read more about Global Health Leadership in Focus: WHO Director-General Dr. Tedros Concludes Landmark State Visit to Jordan

You may have missed

groundbreaking-study-unveils-potent-triple-combination-therapy-offering-unprecedented-hope-against-aggressive-glioblastoma

Groundbreaking Study Unveils Potent Triple-Combination Therapy, Offering Unprecedented Hope Against Aggressive Glioblastoma

Nana Wu November 5, 2026
gan-lees-obesity-drug-maintains-weight-loss-in-phase-iii-trial

Gan & Lee’s obesity drug maintains weight loss in Phase III trial 

Suro Senen November 5, 2026
rekindling-intimacy-navigating-sexual-health-after-breast-cancer-treatment

Rekindling Intimacy: Navigating Sexual Health After Breast Cancer Treatment

Ali Ikhwan November 5, 2026
a-historic-victory-africa-declared-free-of-wild-poliovirus

A Historic Victory: Africa Declared Free of Wild Poliovirus

Ali Ikhwan November 5, 2026